![Pierre Blanchard: Silke Gillessen and Bertrand Tombal, on intermittent ADT/ARPI in metastatic prostrate cancer](https://oncodaily.com/pub/uploads/2024/07/IMG_3756.jpeg)
Photo taken from newatlas.com
Jul 6, 2024, 10:23
Pierre Blanchard: Silke Gillessen and Bertrand Tombal, on intermittent ADT/ARPI in metastatic prostrate cancer
Pierre Blanchard, Radiation Oncology Clinical section chief at Gustave Roussy Cancer Institute, shared on X:
“Excellent discussion by Silke Gillessen, Bertrand Tombal, on intermittent ADT/ARPI in hormone naïve metastatic prostrate cancer at GETUG research days.
New trials needed, especially for patients with deep PSA response (<0,2 ng/ml) after dual ADT/ARPI.”
Source: Pierre Blanchard/X